Oakland, California
February 25, 1999DNAP Holding Corporation announced
year-end and fourth-quarter financial results for the full year
ended December 31, 1998. For the year ended December 31, 1998, DNAP reported a net loss of
$15.6 million, or $0.80 per share, as compared with a loss of $20.3 million, or $1.11 per
share in
1997. DNAP also reported losses from operations of $7.4 million for 1998 compared with a
loss of
$18.5 million for full-year 1997.
Total revenues for full-year 1998 were $262.1 million versus $ 281.2 million for full-year
1997. The
reduction in DNAP's revenue was the result of its divestiture of Royal Van Namen in 1998,
which
accounted for $55.0 million of 1997 revenues. Excluding the revenues associated with Royal
Van
Namen, DNAP's revenues increased by 16% for full-year 1998.
DNAP's net loss decreased to $1.3 million in the fourth quarter of 1998, or $0.05 per
share,
compared with $6.6 million, or $0.36 per share, for the corresponding quarter in 1997.
Total
revenues for the quarter ended December 31, 1998 were $70.7 million, compared with $76.9
million for the same quarter in 1997. For the quarter ended December 31, 1998, revenues in
the
U.S., Canadian, and Mexican distribution operations increased to $66.5 million, an
increase of 6% compared with $62.7 million for the quarter ended December 31, 1997. DNAP
also reflected a
sharp turnaround in its profit from operations of $3.0 million in the 1998 fourth quarter,
compared
with a loss from operations of $4.7 million for the corresponding quarter in 1997. The
significant
improvement in operating profit resulted from the implementation of DNAP's reorganization
and cost cutting in its farming and distribution activities as well as favorable November
and December pricing environments. Also, during the fourth quarter, DNA Plant Technology
Corporation, the Company's research and technology arm, showed a positive operating profit
of $1.5 million due to higher licensing and contract revenues as compared with a loss of
$1.3 million in 1997.
DNAP Holding announced it is close to completing a refinancing of its $85 million in
consolidated
debt. This refinancing, if successfully completed, will result in a three year
$100,000,000 credit
facility that will enable the company to correct the significant working capital imbalance
that has
persisted for several years and relieve the risk associated with the need to continuously
refinance
large short-term lines of credit. This credit facility will be fully guaranteed by DNAP
Holding's parent company, Empresas La Moderna, S.A. de C.V.. Certain restrictions will be
placed on the DNAP Holding with respect to capital investments, acquisitions, dividends,
and use of proceeds from asset sales. It currently is expected this credit facility will
close by mid-March.
DNAP Holding also announced successful outcomes in two lawsuits brought by Grace Brothers
Ltd. against DNA Plant Technology Corporation. The lawsuits related to purchases of DNA
Plant
Technology common and preferred stock made by Grace Brothers Ltd. in 1995 and 1996.
Summary judgments were granted in favor of DNA Plant Technology in both cases during the
past
month. DNAP Holding went on to state that it will vigorously contest two class action
lawsuits filed in January on behalf of former holders of DNA Plant Technology's preferred
stock. The lawsuits allege that there were material misrepresentations and omissions in
the proxy statement/prospectus relating to the 1996 merger of DNA Plant Technology with a
subsidiary of the company. The company believes the claims are without merit.
DNAP Holding Corporation is a leading biotechnology company focused on using its
proprietary
genetic engineering and plant science technologies to develop and improve the quality and
agronomic traits of fruits and vegetables. Through its fresh produce growers and
distribution companies, DNAP is known for its premium Master's Touch® and FreshWorld
Farms® brands. DNAP has strategic joint ventures and licensing agreements with some of
the world's leading agricultural companies, with its affiliates, including Seminis
Vegetable Seeds, Inc., with value-added producers and marketers, and with biotechnology
research groups. DNAP Holding Corporation is majority owned by Mexico's Empresas La
Moderna S.A. de C.V. , whose subsidiaries include the world's biggest vegetable seed
company.
All statements in this press release other than statements of historical facts are
``forward-looking''
statements, including without limitation statements regarding the Company's financial
position,
business strategy, plans and objectives of management, and industry conditions. Although
the
Company believes that the expectations reflected in such forward-looking statements are
reasonable, it can give no assurance that such expectations will prove to be correct. The
following factors, among others, may affect the Company's actual results and could cause
such results to differ materially from those expressed in any forward-looking statements
made by or on behalf of the Company: competitive factors, agribusiness risks, governmental
and economic risks associated with foreign operations, public acceptance of
genetically-engineered products, commercial success of new products, proprietary
protection of and advances in technology, possible need for additional financing, as well
as the ability of the Company to successfully integrate recent acquisitions and its
management information systems and controls. Further information on the factors that could
affect the Company's financial results is contained in the Company's Form 10-K for the
year ended December 31, 1997 which has been filed with the Securities and Exchange
Commission, and will be updated in the Company's Form 10-K for the year ended December 31,
1998 which will be filed on or before March 31, 1999.
DNAP HOLDING CORPORATION
CONSOLIDATED STATEMENT OF OPERATIONS
Thousands of U.S. Dollars (except per share amounts)
. |
Quarter ended Dec. 31 |
Year ended Dec. 31 |
. |
1998 |
1997 |
1998 |
1997 |
Total revenues |
$70,694 |
$76,910 |
$262,111 |
$
281,198 |
Cost of sales |
(57,416) |
(71,011) |
(235,602) |
(262,713) |
Gross Profit |
13,278 |
5,899 |
26,509 |
18,485 |
Selling and
administrative expenses |
(7,886) |
(8,680) |
(25,151) |
(26,660) |
Research and
development expenses |
(1,688) |
(1,375) |
(5,846) |
(5,072) |
Purchased research
and development |
-- |
(2) |
-- |
(2,815) |
Amortization of
goodwill, patents and trademarks |
(746) |
(577) |
(2,940) |
(2,407) |
Operating (loss)
income |
2,959 |
(4,715) |
(7,428) |
(18,469) |
Interest expense |
(2,342) |
(1,853) |
(7,982) |
(5,704) |
Interest income |
431 |
1,195 |
1,285 |
1,964 |
Exchange (loss)
gain, net |
(1,859) |
(854) |
(1,762) |
(481) |
Other
non-operating (expense) income |
(1,198) |
(829) |
(1,119) |
(182) |
Loss before income
tax |
(2,010) |
(7,056) |
(17,006) |
(22,872) |
Income tax
(expense) benefit |
154 |
(444) |
(456) |
(1,426) |
Minority interest
in net loss of subsidiaries |
600 |
925 |
1,857 |
3,986 |
Net loss |
(1,256) |
(6,575) |
(15,605) |
(20,312) |
Net loss per share
- basic and diluted |
$(0.05) |
$(0.36) |
$(0.80) |
$(1.11) |
Weighted average
number of common shares outstanding |
23,301,361 |
18,370,640 |
19,603,320 |
18,370,640 |
|
This schedule contains financial data
extracted from the Company's financial statements at and for the quarter and year ended
December 31, 1998, which will be included in the Company's Form 10-K annual report for
such period, which will be filed on or before March 31, 1999 and is qualified in its
entirety by reference to such financial statements.
N1584 |